- Home
- PAVM vs APVO Comparison
PAVM vs APVO Comparison
Compare PAVM & APVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PAVM
- APVO
- Stock Information
- Founded
- PAVM 2014
- APVO 2016
- Country
- PAVM United States
- APVO United States
- Employees
- PAVM N/A
- APVO N/A
- Industry
- PAVM Medical/Dental Instruments
- APVO Biotechnology: Pharmaceutical Preparations
- Sector
- PAVM Health Care
- APVO Health Care
- Exchange
- PAVM Nasdaq
- APVO Nasdaq
- Market Cap
- PAVM 7.2M
- APVO 6.5M
- IPO Year
- PAVM 2016
- APVO N/A
- Fundamental
- Price
- PAVM $0.65
- APVO $4.14
- Analyst Decision
- PAVM Strong Buy
- APVO Strong Buy
- Analyst Count
- PAVM 1
- APVO 1
- Target Price
- PAVM $19.00
- APVO $296.00
- AVG Volume (30 Days)
- PAVM 210.8K
- APVO 60.9K
- Earning Date
- PAVM 03-25-2025
- APVO 03-04-2025
- Dividend Yield
- PAVM N/A
- APVO N/A
- EPS Growth
- PAVM N/A
- APVO N/A
- EPS
- PAVM 0.53
- APVO N/A
- Revenue
- PAVM $4,034,000.00
- APVO N/A
- Revenue This Year
- PAVM $52.90
- APVO N/A
- Revenue Next Year
- PAVM $248.84
- APVO N/A
- P/E Ratio
- PAVM $1.23
- APVO N/A
- Revenue Growth
- PAVM 166.27
- APVO N/A
- 52 Week Low
- PAVM $0.57
- APVO $3.65
- 52 Week High
- PAVM $3.50
- APVO $399.60
- Technical
- Relative Strength Index (RSI)
- PAVM 45.41
- APVO 36.42
- Support Level
- PAVM $0.62
- APVO $4.46
- Resistance Level
- PAVM $0.70
- APVO $4.64
- Average True Range (ATR)
- PAVM 0.05
- APVO 0.34
- MACD
- PAVM 0.01
- APVO 0.09
- Stochastic Oscillator
- PAVM 61.20
- APVO 29.59
About PAVM PAVmed Inc.
PAVmed Inc is a multi-product, commercial-stage medical technology company organized to advance a broad pipeline of medical technologies from concept to commercialization. The Company operates in a single segment as a medical technology company, with the following lines of business: Diagnostics, Medical Devices, and Digital Health. Its products are EsoGuard, esocheck, and the Veris Cancer Care Platform.
About APVO Aptevo Therapeutics Inc.
Aptevo Therapeutics Inc is a clinical-stage, research and development biotechnology company focused on developing novel immunotherapeutic candidates for the treatment of different forms of cancer. Its clinical candidate, APVO436, and preclinical candidates, ALG.APV-527 and APVO603, were developed using ADAPTIR modular protein technology platform. The versatile and robust ADAPTIR and ADAPTIR-FLEX platforms are designed to generate monospecific, bispecific, and multi-specific antibody candidates that are capable of enhancing the human immune system against cancer cells.